Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves.
Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials
SAN DIEGO — Multiple myeloma patients in the clinic appear to benefit far less from standard treatments when compared with how the same regimens performed
December 11, 2023